Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Silk Road Medical Inc
(NQ:
SILK
)
27.09
-0.02 (-0.06%)
Streaming Delayed Price
Updated: 10:03 AM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Silk Road Medical Inc
< Previous
1
2
3
4
5
6
Next >
Silk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024
April 09, 2024
From
Silk Road Medical
Via
GlobeNewswire
Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUS
April 02, 2024
From
Silk Road Medical
Via
GlobeNewswire
Silk Road Medical Expands TCAR® Portfolio with Launch of Tapered ENROUTE® Transcarotid Stent System
March 05, 2024
From
Silk Road Medical
Via
GlobeNewswire
Breaking Down Silk Road Medical: 5 Analysts Share Their Views
February 29, 2024
Via
Benzinga
Silk Road Medical: Q4 Earnings Insights
February 28, 2024
Via
Benzinga
Expert Outlook: Silk Road Medical Through The Eyes Of 5 Analysts
January 03, 2024
Via
Benzinga
Top 3 Health Care Stocks You May Want To Dump In Q1
February 29, 2024
As of Feb. 29, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Via
Benzinga
Silk Road Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Financial Outlook
February 28, 2024
From
Silk Road Medical
Via
GlobeNewswire
Silk Road Medical to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
February 07, 2024
From
Silk Road Medical
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 23, 2024
Via
Benzinga
Silk Road Medical Inc. (NASDAQ: SILK) Near the Top of Equities by Percentage Gain on 11/13
November 13, 2023
Via
Investor Brand Network
Recap: Silk Road Medical Q3 Earnings
November 08, 2023
Via
Benzinga
Earnings Preview: Silk Road Medical
November 07, 2023
Via
Benzinga
Earnings Scheduled For February 28, 2024
February 28, 2024
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenue of $1.69 billion.
Via
Benzinga
8 Analysts Have This to Say About Silk Road Medical
October 24, 2023
Via
Benzinga
Heart Devices Focused Silk Road Medical Stock Gets an Upgrade - Analyst Says New CEO's Initiatives Sets Stage For 'Back On Track'
January 19, 2024
Stifel's upgraded outlook on Silk Road Medical as CEO Chas McKhann addresses concerns, unveils a compelling vision, and outlines strategic initiatives. Analysts upgrade to Buy with $20 price target,...
Via
Benzinga
Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 19, 2024
Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share. TransCode...
Via
Benzinga
World Acceptance Posts Upbeat Earnings, Joins Kaman, Spirit Airlines And Other Big Stocks Moving Higher On Friday
January 19, 2024
U.S. stocks traded higher, with the Dow Jones index gaining around 50 points on Friday. Shares of World Acceptance Corporation (NASDAQ: WRLD) rose sharply during Friday’s session following upbeat...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Texas Instruments To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday
January 19, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 08, 2024
Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on...
Via
Benzinga
Silk Road Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 20, 2023
From
Silk Road Medical
Via
GlobeNewswire
Silk Road Medical Reports Third Quarter 2023 Financial Results
November 08, 2023
From
Silk Road Medical
Via
GlobeNewswire
Silk Road Medical Names Chas McKhann Chief Executive Officer
November 02, 2023
Accomplished Leader with Over 25 Years of Medical Device Industry Experience
From
Silk Road Medical
Via
GlobeNewswire
Silk Road Medical to Report Third Quarter 2023 Financial Results on November 8, 2023
October 26, 2023
From
Silk Road Medical
Via
GlobeNewswire
NASDAQ:SILK Investor Alert: Investigation over Possible Securities Laws Violations by Silk Road Medical, Inc
October 24, 2023
San Diego, CA -- (SBWIRE) -- 10/24/2023 -- Silk Road Medical, Inc is under investigation over potential securities laws violations in connection with certain financial statements.
Via
SBWire
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023
October 24, 2023
Via
Benzinga
Analysts Downgrade Heart Devices Focused Silk Road Medical, Cite Uncertain Prospects
October 11, 2023
Tuesday, Silk Road Medical Inc (NASDAQ: SILK) reported interim preliminary Q3 revenue expectation of approximately $44.4 million, up 19% Y/Y, lower than the
Via
Benzinga
Crude Oil Down 2.5%; Silk Road Medical Shares Plummet
October 11, 2023
U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Composite gaining around 50 points on Wednesday. The Dow traded down 0.01% to 33,736.15 while the NASDAQ rose 0.42% to...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 11, 2023
Via
Benzinga
Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
October 11, 2023
Gainers Tempest Therapeutics, Inc. (NASDAQ: TPST) shares jumped 1067% to $2.80 after the company released new data demonstrating superiority of TPST-1120 arm across multiple study endpoints in...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.